NetworkNewsBreaks – Willow Biosciences Inc. (TSX
Post# of 23
(Total Views: 100)
Posted On: 01/19/2021 4:56:18 PM
NetworkNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Releases Update on THC, Plans for Canadian Market Launch
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has made advancements on its work on a proprietary yeast strain for the production of Tetrahydrocannabinol (“THC”); the company also announced plans to commercially launch the product in the highly regulated, legal Canadian market. Willow’s Canadian-based R&D (“R&D”) team has developed a proprietary yeast strain along with a process to produce THC; the company is eyeing a pilot scale run by the end of 2021. Willow is operating under the believe that a significant number of consumer product manufacturers are looking for a consistent, high-purity, odorless, flavorless THC ingredient, which is exactly what it is producing. Willow expects the product to be used in the 2.0 market, which includes vapes, edibles, beverages, concentrates and topicals, and has been identified as a multibillion-dollar industry. Willow also announced that it has found a development partner for product isolation, purification and scale up to pilot; in addition, the company is talking with potential manufacturing companies. “We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market,” said Willow president and CEO Trevor Peters in the press release. “Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada , we believe that there is significant demand for consistent, high-purity THC. The flavorless, odorless attributes of our finished product make it suitable as a core ingredient for the cannabis 2.0 market in Canada . There is also strong demand for a more sustainable and environmentally friendly way to produce THC. Our manufacturing process is 50 to 500 times more efficient than indoor cultivation and is the next evolution of sustainable cannabinoid manufacturing.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has made advancements on its work on a proprietary yeast strain for the production of Tetrahydrocannabinol (“THC”); the company also announced plans to commercially launch the product in the highly regulated, legal Canadian market. Willow’s Canadian-based R&D (“R&D”) team has developed a proprietary yeast strain along with a process to produce THC; the company is eyeing a pilot scale run by the end of 2021. Willow is operating under the believe that a significant number of consumer product manufacturers are looking for a consistent, high-purity, odorless, flavorless THC ingredient, which is exactly what it is producing. Willow expects the product to be used in the 2.0 market, which includes vapes, edibles, beverages, concentrates and topicals, and has been identified as a multibillion-dollar industry. Willow also announced that it has found a development partner for product isolation, purification and scale up to pilot; in addition, the company is talking with potential manufacturing companies. “We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market,” said Willow president and CEO Trevor Peters in the press release. “Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada , we believe that there is significant demand for consistent, high-purity THC. The flavorless, odorless attributes of our finished product make it suitable as a core ingredient for the cannabis 2.0 market in Canada . There is also strong demand for a more sustainable and environmentally friendly way to produce THC. Our manufacturing process is 50 to 500 times more efficient than indoor cultivation and is the next evolution of sustainable cannabinoid manufacturing.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Willow Biosciences Inc. (CANSF) Stock Research Links
Scroll down for more posts ▼